Nina Bauer

Global Head of Commercial, Biologics and Viral Vector CTDMO • MilliporeSigma

Dr. Nina Bauer is the Global Head of Commercial for the Biologics and Viral Vector CTDMO Business at MilliporeSigma. Nina’s background is in the Cell and Gene Therapy manufacturing space, with prior stints as Lonza’s Head of Autologous Cell Therapy, FloDesign Sonics’ Chief Commercial Officer, and at the Cell and Therapy Catapult in London. She holds an MA in Biology from Stony Brook University (New York), a PhD in Neuroscience from the University of Oldenburg (Germany), and an MBA from the University of Edinburgh (Scotland). 

Also Speaking

Beth Gardner

Senior Director, Patient Supply • Beam Therapeutics

Amritha Jaishankar

Executive Director, Cell and Gene Therapy Center • IQVIA

Michael Von Forstner

Global Head of Clinical Safety and Pharmacovigilance • Biogen

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.